Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for O60256

Entry ID Method Resolution Chain Position Source
2JI4 X-ray 255 A A 13-369 PDB
AF-O60256-F1 Predicted AlphaFoldDB

184 variants for O60256

Variant ID(s) Position Change Description Diseaes Association Provenance
CA8435258
rs755802625
3 C>Y No ClinGen
ExAC
gnomAD
CA8435259
rs777499681
4 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1271064416
CA398658331
COSM976358
5 T>M Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA398658373
rs1307777855
7 P>L No ClinGen
TOPMed
gnomAD
rs747565574
CA8435263
8 E>G No ClinGen
ExAC
gnomAD
CA8435264
rs769192674
9 L>V No ClinGen
ExAC
gnomAD
rs1455146977
CA398658437
12 K>* No ClinGen
gnomAD
rs1184294027
CA398658445
12 K>R No ClinGen
gnomAD
CA8435266
rs762251868
15 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs765470177
CA8435267
16 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA288480427
rs1025993235
16 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA288480431
rs887474957
17 K>N No ClinGen
TOPMed
gnomAD
rs375894535
CA8435268
18 G>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA288480447
rs1041212379
19 G>D No ClinGen
Ensembl
CA8435269
rs143345926
22 L>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 23 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA288480453
rs868518153
27 S>L No ClinGen
Ensembl
CA8435272
rs754933880
31 C>F No ClinGen
ExAC
gnomAD
CA398658812
rs754933880
31 C>Y No ClinGen
ExAC
gnomAD
CA398658864
rs1333128058
32 M>I No ClinGen
gnomAD
rs199793178
CA8435275
33 E>A No ClinGen
ExAC
gnomAD
CA398658901
rs1242203515
33 E>D No ClinGen
TOPMed
CA8435273
rs543700218
33 E>Q No ClinGen
1000Genomes
ExAC
gnomAD
CA398659035
rs1484007372
39 A>S No ClinGen
TOPMed
rs1485153342
CA398659565
41 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs927260307
CA288481179
COSM170717
41 R>W large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs935020427
CA288481183
43 G>E No ClinGen
TOPMed
CA398659684
rs1597523039
44 V>G No ClinGen
Ensembl
CA398659707
rs1383594880
45 E>K No ClinGen
gnomAD
rs376920336
CA8435295
46 M>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs376920336
CA8435294
46 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1468467085
CA398659776
47 G>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA398659785
rs1270110977
48 K>* No ClinGen
TOPMed
CA8435297
rs763928044
52 Y>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA8435298
rs753619688
54 E>* No ClinGen
ExAC
gnomAD
rs753619688
CA398660125
54 E>K No ClinGen
ExAC
gnomAD
rs915010572
CA288481219
56 N>D No ClinGen
TOPMed
CA398662051
rs1336773373
61 V>L No ClinGen
gnomAD
rs867315151
CA288485032
64 Q>* No ClinGen
Ensembl
rs1261358467
CA398662139
64 Q>R No ClinGen
gnomAD
CA8435315
rs760724775
66 S>T No ClinGen
ExAC
gnomAD
rs750128219
CA8435320
COSM141488
79 S>L upper_aerodigestive_tract Variant assessed as Somatic; 0.0 impact. liver [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs764976325
CA8435319
79 S>P No ClinGen
ExAC
gnomAD
rs765950480
CA8435342
82 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA398663726
rs1294304091
84 T>A No ClinGen
gnomAD
CA288487751
rs187668518
86 I>N No ClinGen
1000Genomes
rs144334691
CA8435343
86 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1260445598
CA398663746
87 M>T No ClinGen
TOPMed
TCGA novel 93 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757819657
CA8435347
96 C>G No ClinGen
ExAC
gnomAD
CA8435348
rs779394846
98 T>I No ClinGen
ExAC
gnomAD
rs746216720
CA8435349
105 I>T No ClinGen
ExAC
gnomAD
rs1342024301
CA398663915
111 F>L No ClinGen
gnomAD
CA8435352
rs376881433
113 Y>* No ClinGen
ESP
ExAC
gnomAD
CA398663948
rs1292425849
116 Q>P No ClinGen
TOPMed
gnomAD
rs1292425849
CA398663949
116 Q>R No ClinGen
TOPMed
gnomAD
CA398663954
rs1275727535
117 C>R No ClinGen
TOPMed
CA398663994
rs1335279295
CA398663990
119 M>I No ClinGen
gnomAD
rs983106828
CA288487792
125 I>V No ClinGen
TOPMed
gnomAD
CA398664080
rs1348556583
126 V>A No ClinGen
gnomAD
rs1026173378
CA288487794
126 V>L No ClinGen
TOPMed
gnomAD
rs748139895
CA8435356
128 K>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs376319376
CA8435358
131 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA398664150
rs1167462030
132 S>P No ClinGen
TOPMed
gnomAD
rs1283964478
CA398664163
133 M>V No ClinGen
gnomAD
rs1434560384
CA398664197
135 C>G No ClinGen
TOPMed
CA398664215
rs1452384062
136 K>Q No ClinGen
gnomAD
rs1158666488
CA398664228
136 K>R No ClinGen
gnomAD
TCGA novel 137 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA288489960
rs975235049
140 T>S No ClinGen
Ensembl
rs763064538
CA288489965
142 L>V No ClinGen
TOPMed
gnomAD
CA398665365
rs1313021049
144 T>S No ClinGen
TOPMed
gnomAD
rs759323687
CA8435383
145 M>T No ClinGen
ExAC
gnomAD
CA8435382
rs774268642
145 M>V No ClinGen
ExAC
gnomAD
rs1480550262
CA398665395
146 D>N No ClinGen
gnomAD
rs1390734082
CA398665424
148 H>P No ClinGen
TOPMed
rs1170651503
CA398665429
148 H>Q No ClinGen
TOPMed
rs1360247418
CA398665517
157 N>S No ClinGen
Ensembl
CA8435385
rs1555551384
158 I>V No ClinGen
Ensembl
TCGA novel 159 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 162 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1465368842
CA398665551
162 N>S No ClinGen
TOPMed
CA8435388
CA398665557
rs374596090
163 L>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs374596090
CA398665558
163 L>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8435389
rs763612893
164 R>K No ClinGen
ExAC
gnomAD
CA288489996
rs764250766
169 L>V No ClinGen
Ensembl
TCGA novel 176 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1438717703
CA398666676
178 P>L No ClinGen
gnomAD
rs1353028527
CA398666835
184 V>I No ClinGen
gnomAD
CA8435412
rs764186666
186 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA398666955
rs1430341181
191 A>T No ClinGen
TOPMed
rs755603988
CA288479256
197 Q>L No ClinGen
Ensembl
rs760877047
CA398655287
201 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA288479262
rs970906662
202 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs764385412
CA8435433
202 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA398655327
rs1210595918
COSM3387735
204 R>C pancreas [Cosmic] No ClinGen
cosmic curated
gnomAD
TCGA novel 204 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs139537704
CA8435435
206 G>E No ClinGen
ESP
ExAC
TOPMed
CA8435436
rs765370145
211 H>R No ClinGen
ExAC
gnomAD
rs780059835
COSM976361
CA8435440
214 A>V Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA288479337
rs373802700
225 R>W No ClinGen
ESP
TOPMed
CA8435447
rs746435131
226 H>N No ClinGen
ExAC
gnomAD
CA398655755
rs1330834316
230 M>V No ClinGen
TOPMed
CA398655779
rs1241687297
231 V>I No ClinGen
gnomAD
CA8435449
rs775797876
232 R>K No ClinGen
ExAC
gnomAD
rs761118277
CA8435450
233 S>N No ClinGen
ExAC
gnomAD
rs776943098
CA8435452
236 A>G No ClinGen
ExAC
gnomAD
rs776943098
CA398655880
236 A>V No ClinGen
ExAC
gnomAD
CA398655886
rs762098241
237 I>L No ClinGen
ExAC
gnomAD
rs1203716311
CA398655893
237 I>T No ClinGen
gnomAD
CA8435453
rs762098241
237 I>V No ClinGen
ExAC
gnomAD
rs1555561175
CA8435455
238 H>P No ClinGen
Ensembl
rs763058406
CA8435458
239 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA8435457
rs750526023
239 P>S No ClinGen
ExAC
gnomAD
rs766352997
CA8435459
240 S>G No ClinGen
ExAC
gnomAD
CA398655970
rs1597713627
241 L>P No ClinGen
Ensembl
rs1248678392
CA398659578
250 E>* No ClinGen
TOPMed
gnomAD
CA398659633
rs1239526133
251 K>M No ClinGen
TOPMed
rs200548082
CA288485603
254 I>V No ClinGen
TOPMed
gnomAD
rs766325318
CA8435480
255 T>M No ClinGen
ExAC
gnomAD
rs267604769
CA8435482
256 V>I No ClinGen
ExAC
gnomAD
CA288485632
rs866207130
258 G>S No ClinGen
Ensembl
CA8435483
rs767401307
265 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA8435484
rs752486623
267 I>V No ClinGen
ExAC
gnomAD
CA398662049
rs1205279277
271 I>V No ClinGen
gnomAD
CA288487769
rs910109862
272 I>V No ClinGen
TOPMed
rs373764009
CA8435531
274 D>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA398662169
rs1287529417
276 D>G No ClinGen
TOPMed
gnomAD
CA398662256
rs1235934813
280 A>D No ClinGen
gnomAD
CA398662260
rs1235934813
280 A>V No ClinGen
gnomAD
rs1256665177
CA398662264
281 A>S No ClinGen
gnomAD
CA398662316
rs1317823989
284 T>N No ClinGen
gnomAD
rs1199863630
CA398662334
285 L>P No ClinGen
gnomAD
rs1239460264
CA398662341
286 K>E No ClinGen
TOPMed
gnomAD
rs1487249998
CA398662361
286 K>N No ClinGen
gnomAD
CA398662400
rs1190210686
288 R>T No ClinGen
gnomAD
rs1267616428
CA398662416
289 G>D No ClinGen
TOPMed
gnomAD
CA8435534
rs757877327
291 Y>C No ClinGen
ExAC
gnomAD
rs1443102459
CA398662444
291 Y>D No ClinGen
TOPMed
rs1422715738
CA398662477
292 K>N No ClinGen
gnomAD
CA8435535
rs765955896
294 F>S No ClinGen
ExAC
gnomAD
CA398662542
rs1402478969
296 M>L No ClinGen
gnomAD
CA398662593
rs1434411992
297 A>V No ClinGen
gnomAD
CA288487788
rs977910346
298 T>S No ClinGen
TOPMed
gnomAD
CA8435536
rs148635892
301 L>F No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 304 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1276661755
CA398662767
306 A>T No ClinGen
gnomAD
CA8435540
rs749621665
308 R>L No ClinGen
ExAC
gnomAD
CA8435539
rs749621665
308 R>Q No ClinGen
ExAC
gnomAD
rs1219764566
CA398662799
308 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA8435542
rs371840452
309 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs779029267
CA8435541
309 R>W No ClinGen
ExAC
gnomAD
CA398662820
rs1597788901
310 I>V No ClinGen
Ensembl
CA398662833
rs1265612575
311 E>K No ClinGen
gnomAD
rs772179015
CA398662902
315 I>L No ClinGen
ExAC
gnomAD
CA8435543
rs772179015
315 I>V No ClinGen
ExAC
gnomAD
CA398663362
rs1235136804
322 N>D No ClinGen
TOPMed
CA8435560
rs779308988
322 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA8435561
rs376952436
324 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA288488536
rs199729642
324 I>V No ClinGen
1000Genomes
rs1567763268
CA398663380
325 P>A No ClinGen
Ensembl
rs866437626
CA288488559
332 Q>* No ClinGen
TOPMed
gnomAD
rs866437626
CA398663430
332 Q>K No ClinGen
TOPMed
gnomAD
rs758607498
CA8435562
332 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs964368447
CA288488565
335 K>E No ClinGen
TOPMed
CA398663465
rs1300410553
337 K>E No ClinGen
gnomAD
rs778957702
CA288488568
337 K>R No ClinGen
gnomAD
CA398663492
rs1303949772
341 I>N No ClinGen
gnomAD
CA8435563
rs369206920
341 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1380623917
CA398663501
342 S>N No ClinGen
gnomAD
rs747098801
CA8435564
348 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs781021630
CA8435566
349 I>S No ClinGen
ExAC
gnomAD
rs1353950523
CA398663547
349 I>V No ClinGen
gnomAD
rs201454078
CA8435567
350 R>C No ClinGen
1000Genomes
ExAC
gnomAD
rs201454078
CA398663552
350 R>G No ClinGen
1000Genomes
ExAC
gnomAD
rs1323821518
CA398663553
350 R>H No ClinGen
TOPMed
rs146759564
CA8435569
351 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 351 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs762759998
CA8435570
351 R>Q No ClinGen
ExAC
gnomAD
CA398663605
rs1451235909
358 M>T No ClinGen
TOPMed
CA8435571
rs770710589
358 M>V No ClinGen
ExAC
gnomAD
CA8435572
rs774092242
360 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA398663617
rs1362387147
360 Y>H No ClinGen
TOPMed
rs759140755
CA8435573
361 L>P No ClinGen
ExAC
gnomAD

No associated diseases with O60256

2 regional properties for O60256

Type Name Position InterPro Accession
domain Phosphoribosyltransferase domain 165 - 323 IPR000836
domain Ribose-phosphate pyrophosphokinase, N-terminal domain 28 - 138 IPR029099

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
ribose phosphate diphosphokinase complex A protein complex having ribose phosphate diphosphokinase activity.

4 GO annotations of molecular function

Name Definition
enzyme inhibitor activity Binds to and stops, prevents or reduces the activity of an enzyme.
identical protein binding Binding to an identical protein or proteins.
magnesium ion binding Binding to a magnesium (Mg) ion.
ribose phosphate diphosphokinase activity Catalysis of the reaction: D-ribose 5-phosphate + ATP = 5-phospho-alpha-D-ribose 1-diphosphate + AMP + 2 H(+).

4 GO annotations of biological process

Name Definition
5-phosphoribose 1-diphosphate biosynthetic process The chemical reactions and pathways resulting in the formation of 5-phosphoribose 1-diphosphate, also known as 5-phosphoribosyl-1-pyrophosphate.
bone development The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
nucleobase-containing compound metabolic process Any cellular metabolic process involving nucleobases, nucleosides, nucleotides and nucleic acids.
purine nucleotide biosynthetic process The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8R574 Prpsap2 Phosphoribosyl pyrophosphate synthase-associated protein 2 Mus musculus (Mouse) PR
10 20 30 40 50 60
MFCVTPPELE TKMNITKGGL VLFSANSNSS CMELSKKIAE RLGVEMGKVQ VYQEPNRETR
70 80 90 100 110 120
VQIQESVRGK DVFIIQTVSK DVNTTIMELL IMVYACKTSC AKSIIGVIPY FPYSKQCKMR
130 140 150 160 170 180
KRGSIVSKLL ASMMCKAGLT HLITMDLHQK EIQGFFNIPV DNLRASPFLL QYIQEEIPDY
190 200 210 220 230 240
RNAVIVAKSP ASAKRAQSFA ERLRLGIAVI HGEAQDAESD LVDGRHSPPM VRSVAAIHPS
250 260 270 280 290 300
LEIPMLIPKE KPPITVVGDV GGRIAIIVDD IIDDVDSFLA AAETLKERGA YKIFVMATHG
310 320 330 340 350 360
LLSSDAPRRI EESAIDEVVV TNTIPHEVQK LQCPKIKTVD ISMILSEAIR RIHNGESMSY
LFRNIGLDD